(Q46105582)

19 December 2017

title

Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative (English)

1 reference

19 December 2017

main subject

foot-and-mouth disease

1 reference

10

Hans J Nauwynck

1 reference

19 December 2017

Nesya Goris

1

1 reference

19 December 2017

Tom Willems

2

1 reference

19 December 2017

Vyacheslav I Diev

3

1 reference

19 December 2017

Petra Merkelbach-Peters

4

1 reference

19 December 2017

Tine Vanbinst

5

1 reference

19 December 2017

Yves Van der Stede

6

1 reference

19 December 2017

Horst-Peter Kraft

7

1 reference

19 December 2017

Valery M Zakharov

8

1 reference

19 December 2017

Vladimir V Borisov

9

1 reference

19 December 2017

Bernd Haas

11

1 reference

19 December 2017

Kris De Clercq

12

1 reference

19 December 2017

language of work or name

English

0 references

publication date

28 May 2008

1 reference

19 December 2017

published in

Vaccine

1 reference

19 December 2017

volume

26

1 reference

19 December 2017

issue

31

1 reference

19 December 2017

page(s)

3870-3879

1 reference

19 December 2017

Prevention measures against foot-and-mouth disease in Europe in recent years

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the “Protection against Podal Generalisation” test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Refinement, reduction, and replacement of animal use for regulatory testing: current best scientific practices for the evaluation of safety and potency of biologicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III. Evaluation of antibodies after infection and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Sources of variability in foot and mouth disease vaccine potency estimates based on serum neutralizing antibody assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Estimating disease prevalence in a Bayesian framework using probabilistic constraints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

A New Asymmetric Measure of Association for Ordinal Variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

The effect of vaccination on foot and mouth disease virus transmission among dairy cows.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

Natural and vaccine induced immunity to FMD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.05.013

1 reference

19 December 2017

1 reference

19 December 2017